Fig. 4.
EFS among AML patients with “normal” plasma sL-selectin levels (<3.12 μg/mL; n = 42; continuous line) or “increased” sL-selectin levels (≥3.12 μg/mL; n = 58; dotted line; P = .008).
EFS among AML patients with “normal” plasma sL-selectin levels (<3.12 μg/mL; n = 42; continuous line) or “increased” sL-selectin levels (≥3.12 μg/mL; n = 58; dotted line; P = .008).
